...
首页> 外文期刊>Experimental Physiology >Role of sex, gonadectomy and sex hormones in the development of nitric oxide inhibition-induced hypertension.
【24h】

Role of sex, gonadectomy and sex hormones in the development of nitric oxide inhibition-induced hypertension.

机译:性别,性腺切除术和性激素在一氧化氮抑制性高血压发展中的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this study we have evaluated the influence of sex, gonadectomy and sex hormones on the development of L-NAME-induced hypertension in the rat, focusing our investigation on blood pressure (BP), plasma renin activity (PRA), cardiac hypertrophy and proteinuria. Three experiments were performed to investigate: (i) the influence of sex on the development of L-NAME-induced hypertension; (ii) the effects of gonadectomy on the dimorphism of L-NAME-induced hypertension; and (iii) the effects of testosterone in ovariectomized female and of 17beta-oestradiol in orchidectomized male rats. Male L-NAME-treated rats had higher BP values than females. Orchidectomy of L-NAME-treated rats reduced BP to the levels of females and ovariectomy did not affect hypertension in females. Oestrogenized and orchidectomized males had a BP level similar to intact female L-NAME-treated rats. However, androgenization and ovariectomy did not change BP in female L-NAME-treated rats. PRA was greater in intact male L-NAME hypertensive rats than in female rats, and gonadectomy protected against the increase in PRA such that PRA was similar among all the groups. Intact female hypertensive rats showed significantly greater ventricular hypertrophy compared with male hypertensive rats. Male L-NAME hypertensive rats had increased proteinuria that was not present in female rats. Moreover, testosterone increased proteinuria in males and females regardless of the BP level. Male L-NAME-treated rats developed higher BP, PRA and proteinuria than female rats, but were more resistant to the development of cardiac hypertrophy. The higher PRA of male L-NAME-treated rats might be involved in the sex-dependent dimorphism of this model of hypertension.
机译:在这项研究中,我们评估了性,性腺切除术和性激素对L-NAME诱导的大鼠高血压发展的影响,重点研究了血压(BP),血浆肾素活性(PRA),心脏肥大和蛋白尿。进行了三个实验以调查:(i)性别对L-NAME诱发的高血压发展的影响; (ii)性腺切除术对L-NAME诱发的高血压双态性的影响; (iii)睾丸激素对去卵巢雌性大鼠的影响和17β-雌二醇对睾丸切除雌性大鼠的影响。雄性L-NAME治疗的大鼠的BP值高于雌性。经L-NAME治疗的大鼠的睾丸切除术将BP降低至雌性水平,而卵巢切除术并未影响雌性高血压。经雌激素处理和经睾丸切除的雄性大鼠的BP水平与接受雌性L-NAME处理的雌性大鼠相似。然而,雄激素化和卵巢切除术并没有改变雌性L-NAME治疗大鼠的血压。完整的雄性L-NAME高血压大鼠的PRA大于雌性大鼠,并且性腺切除术可防止PRA升高,因此所有组中的PRA均相似。与雄性高血压大鼠相比,完整的雌性高血压大鼠表现出明显更大的心室肥大。雄性L-NAME高血压大鼠的蛋白尿增加,而雌性大鼠则没有。此外,无论血压水平如何,睾丸激素都会增加男性和女性的蛋白尿。雄性L-NAME治疗的大鼠比雌性大鼠具有更高的BP,PRA和蛋白尿,但对心脏肥大的发展更具抵抗力。雄性L-NAME治疗的大鼠较高的PRA可能与这种高血压模型的性别依赖性二态有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号